<DOC>
	<DOCNO>NCT02117141</DOCNO>
	<brief_summary>- Assess rate extent absorption hydrocodone 20 mg HC-ER capsule fed fast state - Evaluate safety tolerability test compound administer orally</brief_summary>
	<brief_title>To Assess Rate Extent Absorption Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules</brief_title>
	<detailed_description>Safety parameter assess included medical history , physical examination , vital sign , 12-lead ECGs , clinical laboratory test adverse event assessment .</detailed_description>
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>Healthy Volunteers . Aged great 18 less 45 year . Were medically healthy clinically significant abnormality basis medical history , physical examination laboratory evaluation Volunteer consent participate study . Female volunteer include surgically sterile , use acceptable method birth control define either oral , injectable , implantable , barrier method contraception ( ie , diaphragm spermicidal cream , intrauterine device ( IUD ) spermicidal cream condom spermicidal cream ) . Participants clinical trial within previous 90 day participant narcotic analgesic study within previous 12 month . Deviation excess 10 % ideal body weight height accord Metropolitan Life Insurance Tables ( 1983 edition ) . History drug alcohol abuse time past History hypersensitivity study drug similar compound acetaminophen . Therapeutic use ( reason ) narcotic analgesic within previous year . Subjects use tricyclic antidepressant monoamine oxidase inhibitor time past . Subjects history , clinical sign suggestive , chronic obstructive airway disease . Receipt prescription medication ( except birth control ) within 2 week prior entry study receipt nonprescription overthecounter medication within one week study commencement . ( Vitamin supplement acceptable ) . Blood donation within 90 day previous study entry . Female volunteer positive serum pregnancy test , risk become pregnant study . Volunteers history smoking ( must smoke within last 6 month ) . Volunteers clinical/biochemical impairment liver function , receipt know hepatic enzyme induce inhibit agent within 30 day prior entry study . History presence significant hepatic , renal , endocrine , cardiac , nervous , gastrointestinal , pulmonary metabolic disorder . Any condition history investigator consider might increase risk volunteer interfere evaluation data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Food Effect</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>